5-[3-[4-(3,4-difluorophenyl)piperazin-1-yl]-2-methyl-3-oxopropyl]-5-methylimidazolidine-2,4-dione

C18H22F2N4O3 — CID 121437718

IUPAC5-[3-[4-(3,4-difluorophenyl)piperazin-1-yl]-2-methyl-3-oxopropyl]-5-methylimidazolidine-2,4-dione
SMILESCC(CC1(C)NC(=O)NC1=O)C(=O)N1CCN(c2ccc(F)c(F)c2)CC1
InChIInChI=1S/C18H22F2N4O3/c1-11(10-18(2)16(26)21-17(27)22-18)15(25)24-7-5-23(6-8-24)12-3-4-13(19)14(20)9-12/h3-4,9,11H,5-8,10H2,1-2H3,(H2,21,22,26,27)
InChIKeyZMQVXCLMHVVMKI-UHFFFAOYSA-N
MW380.40 g/mol
LogP1.24
Rot. Bonds4

About 5-[3-[4-(3,4-difluorophenyl)piperazin-1-yl]-2-methyl-3-oxopropyl]-5-methylimidazolidine-2,4-dione

5-[3-[4-(3,4-difluorophenyl)piperazin-1-yl]-2-methyl-3-oxopropyl]-5-methylimidazolidine-2,4-dione (PubChem CID 121437718) has the molecular formula C18H22F2N4O3 and a molecular weight of 380.40 g/mol. Its IUPAC name is 5-[3-[4-(3,4-difluorophenyl)piperazin-1-yl]-2-methyl-3-oxopropyl]-5-methylimidazolidine-2,4-dione.

Molecular Properties

Compound Name5-[3-[4-(3,4-difluorophenyl)piperazin-1-yl]-2-methyl-3-oxopropyl]-5-methylimidazolidine-2,4-dione
PubChem CID121437718
Molecular FormulaC18H22F2N4O3
Molecular Weight380.40 g/mol
Exact Mass380.17
IUPAC Name5-[3-[4-(3,4-difluorophenyl)piperazin-1-yl]-2-methyl-3-oxopropyl]-5-methylimidazolidine-2,4-dione
SMILESCC(CC1(C)NC(=O)NC1=O)C(=O)N1CCN(c2ccc(F)c(F)c2)CC1
InChIInChI=1S/C18H22F2N4O3/c1-11(10-18(2)16(26)21-17(27)22-18)15(25)24-7-5-23(6-8-24)12-3-4-13(19)14(20)9-12/h3-4,9,11H,5-8,10H2,1-2H3,(H2,21,22,26,27)
InChIKeyZMQVXCLMHVVMKI-UHFFFAOYSA-N
XLogP1.24
TPSA81.75 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds4
Heavy Atoms27
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500380.40
LogP ≤ 51.24
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydantoin', 'substructure': 'N/A'}

Analyze 5-[3-[4-(3,4-difluorophenyl)piperazin-1-yl]-2-methyl-3-oxopropyl]-5-methylimidazolidine-2,4-dione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

CID 70556
CID 70556
CID 121448788
CID 121448788
CID 197731
CID 197731
CID 23646334
CID 23646334
CID 2078174
CID 2078174
CID 2161759
CID 2161759
CID 2967472
CID 2967472
CID 3909305
CID 3909305
CID 4694377
CID 4694377
CID 4964169
CID 4964169
CID 9502285
CID 9502285
CID 16290888
CID 16290888

Frequently Asked Questions

What is the IUPAC name of 5-[3-[4-(3,4-difluorophenyl)piperazin-1-yl]-2-methyl-3-oxopropyl]-5-methylimidazolidine-2,4-dione?
The IUPAC name of 5-[3-[4-(3,4-difluorophenyl)piperazin-1-yl]-2-methyl-3-oxopropyl]-5-methylimidazolidine-2,4-dione (CID 121437718) is 5-[3-[4-(3,4-difluorophenyl)piperazin-1-yl]-2-methyl-3-oxopropyl]-5-methylimidazolidine-2,4-dione.
What is the SMILES notation for 5-[3-[4-(3,4-difluorophenyl)piperazin-1-yl]-2-methyl-3-oxopropyl]-5-methylimidazolidine-2,4-dione?
The canonical SMILES for 5-[3-[4-(3,4-difluorophenyl)piperazin-1-yl]-2-methyl-3-oxopropyl]-5-methylimidazolidine-2,4-dione is CC(CC1(C)NC(=O)NC1=O)C(=O)N1CCN(c2ccc(F)c(F)c2)CC1.
What is the InChIKey of 5-[3-[4-(3,4-difluorophenyl)piperazin-1-yl]-2-methyl-3-oxopropyl]-5-methylimidazolidine-2,4-dione?
The InChIKey is ZMQVXCLMHVVMKI-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H22F2N4O3/c1-11(10-18(2)16(26)21-17(27)22-18)15(25)24-7-5-23(6-8-24)12-3-4-13(19)14(20)9-12/h3-4,9,11H,5-8,10H2,1-2H3,(H2,21,22,26,27).
What are the key properties of 5-[3-[4-(3,4-difluorophenyl)piperazin-1-yl]-2-methyl-3-oxopropyl]-5-methylimidazolidine-2,4-dione?
5-[3-[4-(3,4-difluorophenyl)piperazin-1-yl]-2-methyl-3-oxopropyl]-5-methylimidazolidine-2,4-dione has a molecular weight of 380.40 g/mol, XLogP of 1.24, 4 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[3-[4-(3,4-difluorophenyl)piperazin-1-yl]-2-methyl-3-oxopropyl]-5-methylimidazolidine-2,4-dione is sourced from PubChem (CID 121437718), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).